touchLearning Activities
The CALYPSO phase III trial (NCT05778071) evaluated the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism (HypoPT). After 24 weeks, eneboparatide significantly normalized serum calcium levels compared to placebo. The trial found that eneboparatide was well tolerated, with participants continuing treatment for 52 weeks during the extension phase. HypoPT is a rare condition resulting from parathyroid hormone deficiency, affecting calcium regulation. Eneboparatide, a PTH1R agonist, aims to restore stable calcium levels and reabsorption in the kidney. The CALYPSO trial showed promising results, supporting eneboparatide potential as a treatment for HypoPT.
New research, published in the Nature journal, Communications Medicine has identified rare genetic variants that may contribute to the increased prevalence of type 2 diabetes (T2D) in multiple generations of Asian Indian families.1 The findings could provide new insights into ...
"From Adolescence to Menopause: Modern Management of Endometriosis and Uterine Diseases" will be the central theme of the 11th Annual SEUD Congress, taking place April 24–26, 2025, in Prague, Czech Republic. This premier event will unite global experts in gynecology, endometriosis, and uterine disorders to explore the latest advancements in research, diagnosis, and treatment. With an innovative scientific program, engaging discussions, and interactive sessions, SEUD 2025 promises to be an essential gathering for professionals committed to women’s health.
As we observe Rare Liver Disease Month this February, touchENDOCRINOLOGY is proud to join Global Liver Institute (GLI) in championing awareness for rare liver diseases. Although primarily managed within hepatology, many rare liver diseases have strong links to endocrinology due ...
This year the fields of paediatric and adult endocrinology are coming together in a new collaboration. The European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) will co-host their first-ever joint Congress on 10–13 May 2025 at the Bella Centre in Copenhagen, Denmark. This unique event, with the theme ‘Connecting Endocrinology Across the Life Course’, will unite specialists from across the world to foster collaboration, share knowledge and advance clinical care.
Low anti-Müllerian hormone levels tied to fatty liver risk in women: Findings from the CARDIA study
New research presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), The Liver Meeting, reveals a connection between low levels of anti-Müllerian hormone (AMH) and the risk of metabolic-associated steatotic liver disease (...
New research is shedding light on the evolving landscape of liver transplants (LT) for non-cancer conditions in the United States. Dr Abdellatif Ismail (University of Maryland Medical Center, Midtown Campus, Baltimore, MD, USA) focuses on how underlying liver diseases – and ...
In this recent video interview hosted by Sarah Manes, Liver Cancers Program Director at the Global Liver Institute (GLI), medical experts from the USA, Cameroon and Mexico came together to address the significant health disparities in rural communities. The discussion ...
Learn about barriers to effective long-term weight management and pharmacological treatment options for obesity.
The 3-year results from the SURMOUNT-1 trial, published in the New England Journal of Medicine, have revealed that tirzepatide significantly reduced the risk of progression to type 2 diabetes (T2D) in individuals with obesity and prediabetes. T2D onset was ...
As 2024 draws to a close, we’re celebrating a wonderful year of content.
In 2025, the International Diabetes Federation (IDF) will host its World Diabetes Congress in Bangkok, Thailand, from 7-10 April. It will be my immense pleasure to welcome you there as President of the International Diabetes Federation, along with a new Board ...
New research has introduced a strategy that could considerably reduce the need for insulin therapy in patients with type 2 diabetes (T2D)
For hundreds of millions worldwide, diabetes is not just a physical condition, it’s an around-the-clock emotional challenge. Hearing from advocates around the world ahead of World Diabetes Day, it’s clear this burden is shared across the entire diabetes community. Our advocate from Zimbabwe described the constant vigilance and decision-making required to manage his condition, while in Spain they reflected on the unchosen limitations diabetes places on daily life. In India, another advocate highlighted the intense mental strain of balancing work, rest and nutrition. These experiences reveal how daily diabetes management imposes a hidden burden on mental well-being, which is largely unseen by society and unaddressed by healthcare systems.
MACE reduction was a key finding in the topline results from the Semaglutide Cardiovascular Outcomes Trial (SOUL), which reported that oral semaglutide, a long-acting Glucagon-Like Peptide-1 (GLP-1) receptor agonist, significantly decreases the risk of major adverse cardiovascular events in adults with type 2 diabetes (T2D) who have established atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD).
touchENDOCRINOLOGY was delighted to speak with Editorial Board member Dr Deep Dutta, a senior endocrinologist at the CEDAR Superspecialty Clinics, New Delhi, India. Throughout this interview, he summarizes the key messages from his late-breaking abstract session ‘Ailing Heart, Broken Vessels’, presented at the 60th European Association for the Study of Diabetes (EASD) annual meeting in Madrid, Spain.
touchENDOCRINOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
